Classification criteria for antiphospholipid syndrome (APS) require IgG or IgM isotypes of the
anticardiolipin (aCL) antibodies, anti-β2 glycoprotein I (anti-β2GPI) antibodies, and/or the …

Antiphospholipid syndrome (APS) diagnosis hinges on identifying antiphospholipid
antibodies (aPL). Currently, laboratory testing encompasses lupus anticoagulant (LA) …

While lupus anticoagulant (LA), anticardiolipin antibodies (aCL), anti-β 2 glycoprotein I (anti-
β 2 GPI) antibodies represent the best available and the most widely used tests in the …

According to the Sydney criteria, antiphospholipid syndrome (APS) diagnosis is closely
related to the demonstration of antiphospholipid antibodies (aPL) in patients sera. For this …

Current classification criteria for definite antiphospholipid syndrome (APS) mandate the use
of one or more of three positive 'standardized'laboratory assays to detect antiphospholipid …

See also Devreese KMJ, Ortel TL, Pengo V, de Laat B, for the Subcommittee on Lupus
Anticoagulant/Antiphospholipid ID Antibodies. Laboratory criteria for antiphospholipid …

The laboratory criteria (lupus anticoagulants (LA), and/or anti-cardiolipin (aCL) antibodies
and/or anti-β2-glycoprotein I antibodies (aβ2GPI)) that define patients with antiphospholipid …

Classification criteria for antiphospholipid syndrome (APS) require IgG and IgM isotypes of
the anticardiolipin antibodies (aCL), anti-β 2 glycoprotein I antibodies (aβ 2 GPI), and/or the …

Antiphospholipid antibodies (a PL) comprise a heterogeneous group of antibodies directed
against phospholipids and/or protein‐complexed phospholipids. a PL are associated with …

Anticardiolipin antibodies (aCL), anti-β2-glycoprotein I (β2GPI) antibodies and lupus
anticoagulant (LA) are the only laboratory tests considered within the revised criteria for the …